<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Monocytoid B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (MBCL) is a newly recognized, morphologically and immunologically distinct, low-grade B-cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> that may exist as a pure morphologic entity or as a component of a composite <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>To determine whether cytogenetic abnormalities exist in cases of MBCL, fresh tissue from four <z:hpo ids='HP_0002665'>lymphoma</z:hpo> specimens in which MBCL was a substantial component were analyzed by classic cytogenetics; no pure MBCL cases were available for study </plain></SENT>
<SENT sid="2" pm="."><plain>One monoclonal neoplastic population was found in each case by immunophenotyping studies and classic cytogenetics </plain></SENT>
<SENT sid="3" pm="."><plain>Clonal cytogenetic abnormalities included -X or +X, t(14;18)(q32;q21), del(6q), t(11;14)(q13;q32), dup(12q), dup(1q), t(2;3)(q13;q29), and der(8)t(8;9)(p11.2;q13) </plain></SENT>
<SENT sid="4" pm="."><plain>The abnormal clone usually reflected the underlying lymphomatous process, namely, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [t(14;18)], mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [t(11;14)], or small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (partial <z:mp ids='MP_0004027'>trisomy</z:mp> 12) </plain></SENT>
<SENT sid="5" pm="."><plain>There were no cytogenetic abnormalities common to <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, the cytogenetic and immunologic data suggest that although MBCL may exist as a pure entity, it also may commonly represent a morphologic variant or a component of other primary lymphomatous processes </plain></SENT>
</text></document>